Comparison of functional and morphologic changes between brolucizumab and faricimab in neovascular age-related macular degeneration

被引：0
|
作者：
Maruyama-Inoue, Maiko [1 ]
Chin, Jacob Yuhang [2 ]
Kadonosono, Kazuaki [1 ]
机构：
[1] Yokohama City Univ, Med Ctr, Dept Ophthalmol, 4-57 Urafune Cho,Minami Ku, Yokohama, Kanagawa 2320024, Japan
[2] Tan Tock Seng Hosp, Natl Healthcare Grp, Eye Inst, Singapore, Singapore
来源：
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY | 2024年
关键词：
D O I：
10.1007/s00417-024-06516-8
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：3735 / 3736
页数：2
相关论文
共 50 条
  • [1] Comparison of functional and morphologic changes between brolucizumab and faricimab in neovascular age-related macular degeneration
    Maruyama-Inoue, Maiko
    Yanagi, Yasuo
    Inoue, Tatsuya
    Kadonosono, Kazuaki
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2024, 262 (02) : 589 - 599
  • [2] Comparison of functional and morphologic changes between brolucizumab and faricimab in neovascular age-related macular degeneration
    Maiko Maruyama-Inoue
    Yasuo Yanagi
    Tatsuya Inoue
    Kazuaki Kadonosono
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2024, 262 : 589 - 599
  • [3] Comment on "Comparison of functional and morphologic changes between brolucizumab and faricimab in neovascular age-related macular degeneration"
    Stradiotto, E.
    Ottonelli, G.
    Romano, M. R.
    La Spina, C.
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2024, : 3733 - 3734
  • [4] Comparison of Loading Dose between Aflibercept and Faricimab for Neovascular Age-Related Macular Degeneration
    Hara, Chikako
    Suzue, Masaki
    Fujimoto, Satoko
    Fukushima, Yoko
    Sayanagi, Kaori
    Nishida, Kentaro
    Maruyama, Kazuichi
    Sato, Shigeru
    Nishida, Kohji
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (02)
  • [5] Brolucizumab for Neovascular Age-Related Macular Degeneration (BEL Study)
    Van Cleemput, Liesbeth
    Peeters, Freya
    Jacob, Julie
    CLINICAL OPHTHALMOLOGY, 2023, 17 : 1077 - 1085
  • [6] Brolucizumab: an evolution in treatment for neovascular age-related macular degeneration
    Ong, Ee Lin
    Spooner, Kimberly
    Hong, Thomas
    Chang, Andrew
    EXPERT REVIEW OF OPHTHALMOLOGY, 2020, 15 (02) : 71 - 81
  • [7] Faricimab for the Treatment of Diabetic Macular Edema and Neovascular Age-Related Macular Degeneration
    Desideri, Lorenzo Ferro
    Traverso, Carlo Enrico
    Nicolo, Massimo
    Munk, Marion R.
    PHARMACEUTICS, 2023, 15 (05)
  • [8] Intravitreal Brolucizumab for Neovascular Age-Related Macular Degeneration in a Vitrectomized Eye
    Maggio, Emilia
    Alfano, Alessandro
    Mete, Maurizio
    Pertile, Grazia
    CASE REPORTS IN OPHTHALMOLOGY, 2022, 13 (03): : 736 - 743
  • [9] Brolucizumab: evidence to date in the treatment of neovascular age-related macular degeneration
    Yannuzzi, Nicolas A.
    Freund, K. Bailey
    CLINICAL OPHTHALMOLOGY, 2019, 13 : 1323 - 1329
  • [10] The Effectiveness of Brolucizumab and Aflibercept in Patients with Neovascular Age-Related Macular Degeneration
    Musial-Kopiejka, Magdalena
    Polanowska, Katarzyna
    Dobrowolski, Dariusz
    Krysik, Katarzyna
    Wylegala, Edward
    Grabarek, Beniamin Oskar
    Lyssek-Boron, Anita
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (04)
12345